Vigilant Biosciences Announces New Website Launch  September 9, 2020  FORT LAUDERDALE, Fla., Sept. 9, 2020 /PRNewswire/ — Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the

Vigilant Biosciences Names William Brodie as Chief Executive Officer August 7, 2018 FORT LAUDERDALE, Fla., Aug. 7, 2018 /PRNewswire/ — Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and

Vigilant Biosciences Announces Grant Award from National Institutes of Health June 13, 2017 Fort Lauderdale, FLA. Vigilant Biosciences, Inc., a leading innovator and developer of

Vigilant Biosciences Announces Further Clinical Data in Support of its OncAlert™ Oral Cancer Product Line at IFOS ENT World Congress 2017 Symposium and at Annual

Vigilant Biosciences Announces Commencement of FDA Studies for OncAlert™ Cancer Test May 10, 2017 Company begins drive toward FDA clearance of first and only test

Oral Cancer Awareness Survey Reveals 81 Percent of U.S. Adults Want to Be Screened for Oral Cancer During Routine Dental Check-ups; Only 29 Percent Actually